Dexcom | DXCM - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 18.38B 1.88B 2026-03
Align Technology USD 1.91B 2.74M 2026-06
AtriCure USD 81.92M 8.72M 2026-06
Baxter International USD 3.59B 102M 2026-06
Becton, Dickinson and Co. USD 9.4B 897M 2026-06
Boston Scientific USD 6.43B 1.86B 2026-06
Cooper Companies USD 1.8B 209M 2026-03
Dexcom USD 2.36B 133.9M 2026-06
Edwards Lifesciences USD 1.51B 98.9M 2026-06
Globus Medical USD 479.35M 3.12M 2026-06
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 744.2M 56.7M 2026-06
Integra LifeSciences USD 330.88M 15.96M 2026-06
J&J USD 54.9B 2.82B 2026-06
Medtronic USD 9.5B 440M 2025-12
Merit Medical Systems USD 264.93M 48.06M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Solventum Corp USD 3.66B 317M 2026-06
Stryker USD 6.68B 369M 2026-06
Tandem Diabetes Care USD 253M 5.05M 2026-06
Teleflex USD 720.38M 7.67M 2026-06
West Pharmaceutical Services USD 640.5M 33.5M 2026-06
Zimmer Biomet Holdings USD 3.01B 149.2M 2026-06